Tissue expression of transforming growth factor-β1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy
- 30 June 2004
- Vol. 63 (6) , 1191-1197
- https://doi.org/10.1016/j.urology.2003.12.015
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Predictive value of expression of transforming growth factor-?1 and its receptors in transitional cell carcinoma of the urinary bladderCancer, 2001
- Preoperative Plasma Levels of Transforming Growth Factor Beta1 (TGF-β1) Strongly Predict Progression in Patients Undergoing Radical ProstatectomyJournal of Clinical Oncology, 2001
- ELEVATED LEVELS OF CIRCULATING INTERLEUKIN-6 AND TRANSFORMING GROWTH FACTOR-beta 1 IN PATIENTS WITH METASTATIC PROSTATIC CARCINOMAJournal of Urology, 1999
- Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancerThe Prostate, 1998
- Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibitionInternational Journal of Cancer, 1996
- Elevated plasma levels of TGF-β1 in patients with invasive prostate cancerNature Medicine, 1995
- Fresh tissue harvest for research from prostatectomy specimensThe Prostate, 1994
- Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical studyHuman Pathology, 1993
- Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitroMolecular Endocrinology, 1992
- Transforming growth factor β1 as a biomarker for prostate cancerJournal of Cellular Biochemistry, 1992